| Entry |
|
| Name |
Ulinastatin (JP18); Miraclid (TN) |
| Remark |
| Therapeutic category: | 3999 |
|
| Efficacy |
Trypsin inhibitor |
| Target |
|
| Pathway |
| hsa04974 | Protein digestion and absorption |
|
| Interaction |
|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
B BLOOD AND BLOOD FORMING ORGANS
B02 ANTIHEMORRHAGICS
B02A ANTIFIBRINOLYTICS
B02AB Proteinase inhibitors
B02AB05 Ulinastatin
D05183 Ulinastatin (JP18) <JP>
Therapeutic category of drugs in Japan [BR:br08301]
3 Agents affecting metabolism
39 Other agents affecting metabolism
399 Miscellaneous
3999 Others
D05183 Ulinastatin (JP18)
Target-based classification of drugs [BR:br08310]
Peptidases and inhibitors
Serine peptidases
Chymotrypsin family
CTRB
D05183 Ulinastatin (JP18) <JP>
PRSS
D05183 Ulinastatin (JP18) <JP>
ELANE
D05183 Ulinastatin (JP18) <JP>
Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
Chemicals
D05183 Ulinastatin
|
| Other DBs |
|
| LinkDB |
|